Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Frontiers in Pharmacology
Ying WangKun Zhu

Abstract

Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and drugs based on current guidelines for COVID-19 diagnosis and treatment. This can provide a reference for other medical institutions on rational drug use and pharmaceutical care for severe COVID-19 patients.

References

Dec 17, 2004·Journal of Medical Virology·Kao-Jean HuangHuan-Yao Lei
Dec 24, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y ChengG Cheng
Dec 27, 2005·Best Practice & Research. Clinical Haematology·Sheila MacLennan, John A J Barbara
Jan 31, 2006·The American Journal of Medicine·Victor L Serebruany
May 30, 2006·Thrombosis and Haemostasis·Christof SchaeferPaul Merlob
Aug 31, 2006·Annals of Internal Medicine·Thomas C LukeStephen L Hoffman
Jun 5, 2015·The Lancet. Respiratory Medicine·Marta Mora-RilloUNKNOWN La Paz-Carlos III University Hospital Isolation Unit
Aug 18, 2016·Emerging Infectious Diseases·Yaseen M ArabiMashail Alahmadi
May 20, 2017·The Lancet. Respiratory Medicine·John H BeigelUNKNOWN IRC002 Study Team
Feb 1, 2020·The New England Journal of Medicine·Michelle L HolshueUNKNOWN Washington State 2019-nCoV Case Investigation Team
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Mar 3, 2020·The Lancet Infectious Diseases·Long ChenYuan Shi
Mar 19, 2020·The New England Journal of Medicine·Bin CaoChen Wang
Apr 23, 2020·Research in Social & Administrative Pharmacy : RSAP·Wang YingZhu Kun

❮ Previous
Next ❯

Citations

May 6, 2020·Journal of Medical Virology·Jialin Liu, Siru Liu
Sep 3, 2020·The New England Journal of Medicine·Cheryl KeechGregory M Glenn
Oct 13, 2020·The Cochrane Database of Systematic Reviews·Khai Li ChaiNicole Skoetz
Dec 3, 2020·Risk Management and Healthcare Policy·Nandeeta SamadMainul Haque
May 21, 2021·The Cochrane Database of Systematic Reviews·Vanessa PiechottaNicole Skoetz

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Minerva medica
Beuy Joob, Viroj Wiwanitkit
JAMA : the Journal of the American Medical Association
Anurag N MalaniPreeti N Malani
BMJ : British Medical Journal
Lise Estcourt, David J Roberts
Proceedings of the National Academy of Sciences of the United States of America
Furong ZengGuangtong Deng
European Journal of Internal Medicine
Massimo Franchini
© 2021 Meta ULC. All rights reserved